153 related articles for article (PubMed ID: 9688795)
61. [Percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma].
Ebara M; Fukuda H; Yoshikawa M; Sugiura N; Saisho H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():545-51. PubMed ID: 11762009
[No Abstract] [Full Text] [Related]
62. Assessment of therapeutic effect of liver tumor ablation procedures.
Bartolozzi C; Crocetti L; Cioni D; Donati FM; Lencioni R
Hepatogastroenterology; 2001; 48(38):352-8. PubMed ID: 11379308
[TBL] [Abstract][Full Text] [Related]
63. Percutaneous Ethanol Injection in the treatment of hepatocellular carcinoma in cirrhosis.
Livraghi T
Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1248-53. PubMed ID: 9730383
[No Abstract] [Full Text] [Related]
64. [Percutaneous hot ethanol injection therapy (PHEIT)].
Nakai M; Sato M; Kawai N
Nihon Rinsho; 2001 Oct; 59 Suppl 6():552-7. PubMed ID: 11762011
[No Abstract] [Full Text] [Related]
65. [Management of complications associated with local ablation therapy for hepatocellular carcinoma].
Obi S; Shiina S; Imamura M; Teratani T; Satoh S; Koike Y; Ishikawa T; Akamatsu M; Fujishima T; Tateishi R; Omata M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():606-11. PubMed ID: 11762021
[No Abstract] [Full Text] [Related]
66. Intra-arterial carbon dioxide-enhanced ultrasonogram of hepatocellular carcinoma treated by transcatheter arterial embolization and percutaneous ethanol injection therapy.
Chen RC; Wang CK; Chiang LC; Lo HY; Duh SJ; Chen WT; Tu HY; Liao LY; Wang CS; Chen PH
J Gastroenterol Hepatol; 1998 Jan; 13(1):41-6. PubMed ID: 9737570
[TBL] [Abstract][Full Text] [Related]
67. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection.
Lencioni R; Caramella D; Bartolozzi C
Radiology; 1995 Jan; 194(1):113-8. PubMed ID: 7997536
[TBL] [Abstract][Full Text] [Related]
68. [Good response in case of hepatocellular carcinoma; a case report of interdisciplinary local therapy].
Niinobu T; Shibata T; Shibata N; Takada T; Kitada M; Tsukahara Y; Hata S; Ikeda K; Hayashida H; Ogawa M; Hayashi N; Akazawa K; Takami M
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1379-81. PubMed ID: 9703833
[TBL] [Abstract][Full Text] [Related]
69. Comparison of techniques for image-guided ablation of focal liver tumors.
Goldberg SN
Radiology; 2002 May; 223(2):304-7. PubMed ID: 11997528
[No Abstract] [Full Text] [Related]
70. [Interstitial percutaneous therapies in primary and secondary liver tumors].
Torzilli G; Livraghi T; Olivari N
Ann Ital Chir; 1999; 70(2):185-94. PubMed ID: 10434450
[TBL] [Abstract][Full Text] [Related]
71. Subcutaneous metastasis following percutaneous ethanol injection therapy for hepatocellular carcinoma.
Yano S; Nakamura K; Yamane K; Kakinuma T; Asahina A; Tamaki K
Acta Derm Venereol; 2001; 81(3):213-4. PubMed ID: 11558885
[No Abstract] [Full Text] [Related]
72. Flash echo gray scale imaging with subtraction in assessment of small hepatocellular carcinoma treated with percutaneous ethanol injection: preliminary report.
Wang JH; Lu SN; Changchien CS; Lee CM; Tung HD; Chen TM
J Ultrasound Med; 2001 May; 20(5):539-44. PubMed ID: 11345112
[TBL] [Abstract][Full Text] [Related]
73. [Non-Surgical tumor ablation of hepatocellular carcinoma].
Koike Y; Omata M
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1276-9. PubMed ID: 14518406
[TBL] [Abstract][Full Text] [Related]
74. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
Huo TI; Huang YH; Chiang JH; Wu JC; Lee PC; Chi CW; Lee SD
Scand J Gastroenterol; 2007 Apr; 42(4):485-92. PubMed ID: 17454859
[TBL] [Abstract][Full Text] [Related]
75. Intralesional injection for hepatic metastasis from cervical carcinoma. A report of two cases.
Chao A; Lai CH; Hsueh S; Lin SM; Chang TC
J Reprod Med; 2001 Nov; 46(11):1008-12. PubMed ID: 11762144
[TBL] [Abstract][Full Text] [Related]
76. Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis.
Kiba T; Numata K; Kitamura T; Morita K; Saito S; Sekihara H
Hepatogastroenterology; 2001; 48(38):427-31. PubMed ID: 11379324
[TBL] [Abstract][Full Text] [Related]
77. [Current status of treatment for small hepatocellular carcinoma].
Yokoi H; Kawarada Y
Gan To Kagaku Ryoho; 1996 Jun; 23(7):855-61. PubMed ID: 8678533
[TBL] [Abstract][Full Text] [Related]
78. Percutaneous local therapies for hepatocellular carcinoma impair gastric function.
Kinekawa F; Matsuda K; Masaki T; Kurokohchi K; Yoneyama H; Inoue H; Kurata H; Uchida Y; Watanabe S; Kuriyama S
World J Gastroenterol; 2006 Jan; 12(1):157-8. PubMed ID: 16440439
[No Abstract] [Full Text] [Related]
79. Percutaneous intravascular ethanol injection of the supplying tumor vessel in the treatment of hepatocellular carcinoma larger than 3 cm.
Lin ZY; Wang JH; Wang LY; Lu SN; Chen SC; Chuang WL; Hsieh MY; Tsai JF; Chang WY
J Ultrasound Med; 1996 Feb; 15(2):155-60. PubMed ID: 8622192
[TBL] [Abstract][Full Text] [Related]
80. Large infiltrative hepatocellular carcinomas: treatment with percutaneous intraarterial ethanol injection alone or in combination with conventional percutaneous ethanol injection.
Seror O; N'Kontchou G; Haddar D; Dordea M; Ajavon Y; Ganne N; Trinchet JC; Beaugrand M; Sellier N
Radiology; 2005 Jan; 234(1):299-309. PubMed ID: 15564388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
